Swedish Orphan Biovitrum AB's total assets for Q1 2026 were kr81.26B, an increase of 20.50% from the previous quarter. DE:B6E total liabilities were kr40.87B for the fiscal quarter, a 37.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.